Insomnia: The Evidence-Based Supplement Protocol

6 min read ·
Bottom Line

For chronic insomnia the first-line treatment is cognitive behavioral therapy (CBT-I), not a pill or powder — it works better and lasts longer than any drug or supplement, with no dependence risk. Among supplements, only a few have credible trial evidence and even the best is modest: low-dose melatonin (0.3–0.5 mg) shaved only about 7 minutes off time to fall asleep and is really a circadian signal best for jet lag and shift work, where timing matters more than dose. Magnesium, glycine, and L-theanine have weaker, mostly small-trial support and are reasonable low-risk add-ons rather than proven therapies. Skip the multi-ingredient "sleep formulas" that stack subclinical doses, and note that effective melatonin doses are far below the 5–10 mg most products sell.

Chronic insomnia is best treated with cognitive behavioral therapy for insomnia (CBT-I), not a pill or a powder. The American College of Physicians guideline gives CBT-I a strong recommendation as the initial treatment for all adults with chronic insomnia, reserving medication for a shared-decision discussion only when CBT-I alone fails—because its benefits are larger and longer-lasting than any drug or supplement, with none of the dependence risk. Start there. Among supplements, only a small set has credible randomized-trial evidence, and even the best of it is modest; most commercial "sleep formulas" stack many ingredients at subclinical doses with no head-to-head data. Here is what the evidence actually supports, graded honestly, and what to skip.

Melatonin — Low Dose (0.3–0.5 mg), Timed Correctly — Moderate but Modest

Melatonin is the best-evidenced sleep supplement, but the effect is small and it is more a circadian signal than a sedative. A meta-analysis of 19 randomized placebo-controlled trials (1,683 subjects) found melatonin reduced sleep-onset latency by about 7 minutes, increased total sleep time by about 8 minutes, and modestly improved overall sleep quality—benefits the authors describe as real but smaller than prescription hypnotics, with a benign side-effect profile. Its clearest role is in circadian-rhythm problems: delayed sleep-phase, jet lag, and shift work. A phase-response-curve study shows that timing matters far more than dose—a low dose taken in the late afternoon or early evening (hours before bedtime) shifts the body clock, whereas the same dose at bedtime mainly has a weak direct soporific effect. Effective doses (0.3–0.5 mg) are far lower than the 5–10 mg most products sell. See our melatonin dosing piece.

Magnesium, 200–500 mg Elemental Nightly — Limited/Weak

Magnesium is a plausible but weakly supported sleep aid. The most-cited trial is a small double-blind RCT of 46 older adults with insomnia, in which 500 mg/day of magnesium for eight weeks improved subjective sleep efficiency, sleep time, sleep-onset latency, and Insomnia Severity Index score versus placebo, alongside higher serum melatonin and lower cortisol. The effect is modest and the evidence base is thin—mostly small, short trials at risk of bias—so treat magnesium as a low-risk adjunct rather than a proven therapy. It is most reasonable for people who are not getting enough dietary magnesium. The glycinate form is gentler on the gut than oxide or citrate (which can loosen stools); take it with the evening meal. See our magnesium glycinate piece.

Glycine, 3 g Before Bed — Limited (Promising but Small)

Glycine 3 g taken before bed has a small but interesting trial signal: the research group that studied it reports it improves subjective sleep quality in people with insomniac tendencies and reduces next-day fatigue after sleep restriction, with a proposed mechanism of lowering core body temperature (a normal trigger for sleep onset) via increased peripheral blood flow. It is cheap and well tolerated. The caveats are real: the human trials are small and were conducted by a manufacturer (Ajinomoto), and independent replication is limited—so this is a reasonable low-risk experiment, not an established treatment. See our glycine piece.

L-Theanine, 200 mg in the Evening — Limited (Better for Worry than Sedation)

L-theanine does not sedate; it appears to ease the anxious arousal that keeps ruminative minds awake. In a randomized, placebo-controlled crossover trial in healthy adults, four weeks of L-theanine 200 mg/day improved several Pittsburgh Sleep Quality Index subscales—sleep latency, sleep disturbance, and use of sleep medication—and lowered anxiety and depression scores. It is best viewed as a calming adjunct for stress- or worry-driven insomnia alongside CBT-I, not a hypnotic; its standalone effect on anxiety in pooled analyses is inconsistent.

Tart Cherry — Insufficient/Weak

Tart Montmorency cherries contain small amounts of melatonin and tryptophan, which generated interest in tart cherry juice for sleep. The reality is underwhelming. A pilot RCT in 15 older adults with insomnia found tart cherry juice significantly reduced minutes awake after sleep onset versus placebo, but produced no significant improvement in sleep-onset latency, total sleep time, or sleep efficiency, with effect sizes the authors called moderate to negligible—and far below those of hypnotics or CBT-I. A separate trial in healthy adults raised melatonin and modestly improved sleep measures. Bottom line: a benign food-based option with a weak, inconsistent signal, not a reliable insomnia treatment. See our tart cherry sleep piece.

What Does Not Work, or Is Overhyped

Valerian is the classic example of an herb that underperforms its reputation: a systematic review of 16 trials (1,093 patients) found most studies had significant methodological problems and evidence of publication bias, leaving its benefit uncertain and product potency highly variable—so we do not recommend relying on it. Avoid kava for sleep given its hepatotoxicity risk. Skip "sleep formula" megaproducts with 10-plus ingredients at subclinical doses—you cannot tell what, if anything, is working. Do not start prescription Z-drugs (zolpidem, eszopiclone) or benzodiazepines for chronic insomnia without sleep-medicine input, because of tolerance, dependence, and complex sleep behaviors. And do not stack several sedating supplements at once (melatonin plus valerian plus magnesium plus L-theanine plus glycine): the overlap makes both benefit and side effects impossible to interpret, and persistent insomnia despite a sensible trial deserves a clinical work-up, not more capsules.

How to Run the Protocol

Put CBT-I and sleep hygiene first—they carry by far the strongest evidence and are the only approach shown to durably resolve chronic insomnia. If you add a supplement, change one thing at a time so you can judge it. For a sleep-onset or stress-driven pattern, a reasonable single trial is L-theanine 200 mg or glycine 3 g in the evening, or magnesium glycinate (200–400 mg elemental) with dinner. Reserve low-dose melatonin (0.3–0.5 mg) mainly for circadian-timing problems such as jet lag or delayed sleep-phase, taking it earlier in the evening rather than at lights-out. Re-evaluate with a sleep diary at four weeks; if insomnia persists, or if you have loud snoring, witnessed apneas, or unrefreshing sleep, see a sleep-medicine clinician to assess for sleep apnea and other disorders before escalating. See the evidence-based sleep stack.

Sources

  1. Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD. "Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians." Annals of Internal Medicine, 2016;165(2):125-133. PMID 27136449.
  2. Ferracioli-Oda E, Qawasmi A, Bloch MH. "Meta-analysis: melatonin for the treatment of primary sleep disorders." PLOS ONE, 2013;8(5):e63773. PMID 23691095.
  3. Burgess HJ, Revell VL, Eastman CI. "A three pulse phase response curve to three milligrams of melatonin in humans." The Journal of Physiology, 2008;586(2):639-647. PMID 18006583.
  4. Abbasi B, Kimiagar M, Sadeghniiat K, Shirazi MM, Hedayati M, Rashidkhani B. "The effect of magnesium supplementation on primary insomnia in elderly: a double-blind placebo-controlled clinical trial." Journal of Research in Medical Sciences, 2012;17(12):1161-1169. PMID 23853635.
  5. Bannai M, Kawai N. "New therapeutic strategy for amino acid medicine: glycine improves the quality of sleep." Journal of Pharmacological Sciences, 2012;118(2):145-148. PMID 22293292.
  6. Hidese S, Ogawa S, Ota M, et al. "Effects of L-theanine administration on stress-related symptoms and cognitive functions in healthy adults: a randomized controlled trial." Nutrients, 2019;11(10):2362. PMID 31623400.
  7. Bent S, Padula A, Moore D, Patterson M, Mehling W. "Valerian for sleep: a systematic review and meta-analysis." The American Journal of Medicine, 2006;119(12):1005-1012. PMID 17145239.
  8. Pigeon WR, Carr M, Gorman C, Perlis ML. "Effects of a tart cherry juice beverage on the sleep of older adults with insomnia: a pilot study." Journal of Medicinal Food, 2010;13(3):579-583. PMID 20438325.